期刊文献+

不稳定心绞痛患者脂蛋白(a)、纤维蛋白原水平及血小板聚集率的临床意义研究 被引量:13

下载PDF
导出
摘要 目的:观察不稳定心绞痛(UAP)患者脂蛋白(a)(Lp(a))、纤维蛋白原(Fg)水平及血小板聚集率(PAG)的变化,探讨其与UAP的关系及临床意义。方法:比较110例UAP患者(UAP组)与111例对照(对照组)一般临床资料、空腹血糖(FBG)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-c)、高密度脂蛋白胆固醇(HDL-c)、极低密度脂蛋白胆固醇(VLDL-c)、载脂蛋白A(apoA)、载脂蛋白B(apoB)、Lp(a)、Fg水平及最大血小板聚集率(PAGM)的差别。Logistic回归分析Lp(a)、Fg水平及PAGM与UAP的关系。结果:(1)两组一般临床资料均无统计学差异(P>0.05)。(2)UAP组Lp(a)、Fg水平及PAGM均显著高于对照组(分别为(0.223±0.156)比(0.170±0.124)mmol/l,P=0.005;(3.619±0.726)比(3.303±0.646)mg/dl,P=0.001;(45.427±11.002)%比(38.888±7.844%,P<0.01),两组BMI、FBG、TC、TG、LDL-c、HDL-c、VLDL-c、apoA、apoB及血小板计数均无统计学差异(P>0.05)。(3)PAGM与Fg水平呈正相关(r=0.167,P=0.013),与Lp(a)水平无相关性(r=0.064,P=0.345),Lp(a)与Fg水平正相关(r=0.254,P<0.001)。(4)Logistic回归分析高Lp(a)、Fg水平及PAG与不稳定心绞痛发生有关。结论:UAP患者Lp(a)、Fg水平及PAG均显著升高,是UAP发生的危险因素,在临床工作中应高度重视。
出处 《实用医学杂志》 CAS 北大核心 2011年第4期607-609,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献10

  • 1陈海英,曲鹏,丁彦春,宋慧君,牛楠,徐丹,李蕾.单核细胞Toll样受体4信号通路在不稳定型心绞痛炎症反应中的作用探讨[J].实用医学杂志,2009,25(23):3987-3989. 被引量:2
  • 2吴常裕.阿司匹林抵抗与不稳定型心绞痛的临床研究[J].实用医学杂志,2009,25(13):2091-2092. 被引量:16
  • 3Bennet A,Angelantonio E,Erqou S,et al.Lipoprotein(a) levels and risk of future coronary heart disease:large-scale prospective data[J].Arch Intern Med,2008,24,168(6):598-608.
  • 4Zlatohlávek L,Zídková K,Vrablík M,et al.Lipoprotein(a) and its position among other risk factors of atherosclerosis[J].Physiol Res,2008,57(5):777-783.
  • 5Danik J S,Paré G,Chasman D I,et al.Novel loci,including those related to Crohn disease,psoriasis,and inflammation,identified in a genome-wide association study of fibrinogen in 17 686 women:the Women′s Genome Health Study[J].Circ Cardiovasc Genet,2009,2(2):134-41.
  • 6Danesh J,Lewington S,Thompson S G,et al.Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality:an individual participant meta-analysis[J].JAMA,2005,294(14):1799-1809.
  • 7Koenig W.Fibrinogen in cardiovascular disease:an update[J].Thromb Haemost,2003,89(4):601-609.
  • 8Shai I,Rimm E B,Hankinson S E,et al.Lipoprotein(a) and coronary heart disease among women:beyond a cholesterol carrier[J].Eur Heart J,2005,26(16):1633-1639.
  • 9Lominadze D,Dean W L,Tyagi S C,et al.Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease[J].Acta Physiol,2010,198(1):1-13.
  • 10Eriksson A C,Jonasson L,Lindahl T L,et al.Static platelet adhesion,flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease:a randomised cross-over study[J].J Transl Med,2009,7:42.

二级参考文献16

  • 1Geng HL Lu HQ Zhang LZ Zhang H Zhou L Wang H Zhong RQ.Increased expression of Toll-like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease[J].第二军医大学学报,2006,27(5):537-537. 被引量:20
  • 2吴兆增,骆美瑛,李梅,仇为民,史宝强,杨庆祥.冠心病患者细胞因子测定的临床意义[J].放射免疫学杂志,2006,19(4):293-295. 被引量:7
  • 3胡大一,孙艺红.正确认识阿司匹林“抵抗”[J].中华心血管病杂志,2006,34(12):1057-1058. 被引量:10
  • 4Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high-risk patients[J].BMJ,2002,324(7329):103-105.
  • 5Gum P A,Kottke-Marchant K,Welsh P A,et al.A prospective,blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease[J].J Am Coll Cardiol,2003,41 (6):961-965.
  • 6Antithrombotic Trialists' Collaboration[J].BMJ,2002,324(7329):71-86.
  • 7Eikelboom J W.Hznkev G J.Aspirin resistance:a new independent predictor of vascular events[J].J Am Coll Cardiol,2003,41 (11):966-968.
  • 8Gum P A,Kandice K M,Welsh P A,et al.A prospective,blinded determination of the natural history of aspirin resistance among stable patients with cardiovaacular disease[J].J Am Coll Cardiol,2003,41(6):961-965.
  • 9Weber A A,Zimmerman K C,Meyer-Kirchrath J,et al.Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance[J].Lancet,1999,353(9156):900.
  • 10Kawasaki T,Ozeki Y,Igawa T,et al.Increased platelet sensitivity to collgen in individuals resistant to low-dose aspirin[J].Stroke,2000,31(3):591-595.

共引文献16

同被引文献122

引证文献13

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部